Abstract
Imatinib (trade name Gleevec) preserves fertility in female mice treated with the common chemotherapeutic agent cisplatin. Imatinib seems to block an apoptotic pathway activated by cisplatin in ovarian germ cells (pages 1179-1185). The findings could lead to new ways to protect germ cells from the damaging effects of cancer treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1124-1125 |
| Number of pages | 2 |
| Journal | Nature Medicine |
| Volume | 15 |
| Issue number | 10 |
| DOIs | |
| State | Published - Nov 4 2009 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Fingerprint Dive into the research topics of 'Preserving fertility during cancer treatment'. Together they form a unique fingerprint.
Cite this
Woodruff, T. K. (2009). Preserving fertility during cancer treatment. Nature Medicine, 15(10), 1124-1125. https://doi.org/10.1038/nm1009-1124